Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

CD38 KO /CD38-CAR Human Primary Natural Killer Cells Enhance Cytotoxicity Against CD38-Expressing Primary Lymphoma, Leukemia, and Myeloma

Ella C Troy, Yasemin Sezgin, Marcelo De Souza Pereira, Joseph Caporale, Gregory K Behbehani, Justin Lyberger, Dean Anthony Lee, Meisam Naeimi Kararoudi

Blood (2023) 142 (Supplement 1): 3443.

https://doi.org/10.1182/blood-2023-174742

Published: 2023

Journal Articles

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

Shrijan Khanal, Lotus Neidemire-Colley, Kara M Braunreiter, Katiri Snyder, Yandi Gao, Sonu Kalyan, Meisam Naeimi Kararoudi, Molly Erin Duszynski, Mengna Chi, Punam Malik, Hannah Choe, Ramiro Garzon, Parvathi Ranganathan

Blood (2022) 140 (Supplement 1): 10200–10201.

https://doi.org/10.1182/blood-2022-159599

Published: 2022

Journal Articles

CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

Meisam Naeimi Kararoudi, Yuya Nagai, Ezgi Elmas, Marcelo de Souza Fernandes Pereira, Syed Abbas Ali, Philip Hollingsworth Imus, Darren Wethington, Ivan Marques Borrello, Dean Anthony Lee, Gabriel Ghiaur

Blood (2020) 136 (21): 2416–2427.

https://doi.org/10.1182/blood.2020006200

Published: 2020

Includes: Supplemental data

Journal Articles

CD33 Targeting Primary CAR-NK Cells Generated By CRISPR Mediated Gene Insertion Show Enhanced Anti-AML Activity

Meisam Naeimi Kararoudi, PhD DVM, Shibi Likhite, PhD, Ezgi Elmas, Maura Schwartz, Kinnari Sorathia, Kenta Yamamoto, Nitin Chakravarti, PhD, Branden S Moriarity, PhD, Kathrin Meyer, PhD, Dean Anthony Lee, MD PhD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-142494

Published: 2020

Journal Articles

CD38 Knockout Primary NK Cells to Prevent "Fratricide" and Boost Daratumumab Activity

Yuya Nagai, MD, Meisam Naeimi Kararoudi, PhD DVM, Ezgi Elmas, MS, Marcelo Pereira, Syed Abbas Ali, MD, Philip Hollingsworth Imus, MD, Dean Anthony Lee, MD PhD, Gabriel Ghiaur, MD PhD

Blood (2019) 134 (Supplement_1): 870.

https://doi.org/10.1182/blood-2019-129456

Published: 2019

Journal Articles

Disruption of SOCS3 Promotes the Anti-Cancer Efficacy of Primary NK Cells

Meisam Naeimi Kararoudi, PhD DVM, Ezgi Elmas, MS, Margaret Lamb, MD, Nitin Chakravarti, PhD, Prashant Trikha, PhD, Dean Anthony Lee, MD PhD

Blood (2018) 132 (Supplement 1): 5687.

https://doi.org/10.1182/blood-2018-99-116621

Published: 2018

NARROW

CD38 KO /CD38-CAR Human Primary Natural Killer Cells Enhance Cytotoxicity Against CD38-Expressing Primary Lymphoma, Leukemia, and Myeloma

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

CD33 Targeting Primary CAR-NK Cells Generated By CRISPR Mediated Gene Insertion Show Enhanced Anti-AML Activity

CD38 Knockout Primary NK Cells to Prevent "Fratricide" and Boost Daratumumab Activity

Disruption of SOCS3 Promotes the Anti-Cancer Efficacy of Primary NK Cells

Email alerts

ASH Publications

American Society of Hematology

CD38 KO /CD38-CAR Human Primary Natural Killer Cells Enhance Cytotoxicity Against CD38-Expressing Primary Lymphoma, Leukemia, and Myeloma

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

CD33 Targeting Primary CAR-NK Cells Generated By CRISPR Mediated Gene Insertion Show Enhanced Anti-AML Activity

CD38 Knockout Primary NK Cells to Prevent "Fratricide" and Boost Daratumumab Activity

Disruption of SOCS3 Promotes the Anti-Cancer Efficacy of Primary NK Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only